Other safety alerts
|
| |
| China: Alert on metoclopramide-induced extrapyramidal reactions |
| |
In Hong Kong, there are 33 registered pharmaceutical products containing metoclopramide. All of them are prescription-only medicines. Related news has been released by the EMA, Singapore HSA, Health Canada and the TGA, and was posted on the Drug Office website on 27 July 2013, 24 July 2014, 6 January 2015 and 2 February 2015 respectively. Letters to inform healthcare professionals to draw their attention to the issue and urge them to report any adverse drug reaction related to the drug was issued on 29 July 2013. As previously reported, the matter was discussed in the meeting of the Registration Committee of the Pharmacy and Poisons Board (the Committee) in September 2014. The Committee decided that the sales pack label and/or package insert of metoclopramide containing products should be updated to include the appropriate safety information. So far, the Department of Health (DH) has not received any adverse reaction report related to the drug. The DH will keep vigilant on the safety updates of the drug.
Please refer to the following Chinese website for details:
http://www.drugoffice.gov.hk/eps/news/../24680.html
Ends/ Saturday, April 25, 2015
Issued at HKT 13:30
|
| |
|
